Neuroimmunological Response in Neuro-Behçet's

Castillo González, 2014, Enfermedad de Behçet, Rev Cuba Reumatol, 16, 309 Davatchi, 2014, The International Criteria for Behçet's Disease (ICBD): A collaborative study of 27 countries on the sensitivity and specificity of the new criteria, J Eur Acad Dermatol Venereol, 28, 338, 10.1111/jdv.12107 García-Rivero, 2015, Neurobehçet, Rev Cuba Reumatol, 17, 222 Reiber, 2016, Cerebrospinal fluid data compilation and knowledge-based interpretation of bacterial, viral, parasitic, oncological, chronic inflammatory and demyelinating diseases. Diagnostic patterns not to be missed in neurology and psychiatry, Arq Neuropsiquiatr, 74, 337, 10.1590/0004-282X20160044 Dorta-Contreras, 2007 Lopalco, 2015, Putative role of serum amyloid-A and proinflammatory cytokines as biomarkers for Behcet's disease, Medicine (Baltimore), 94, e1858, 10.1097/MD.0000000000001858 Lee, 2012, Differential expression of T cell immunoglobulin- and mucin-domain-containing molecule-3 (TIM-3) according to activity of Behcet's disease, J Dermatol Sci, 65, 220, 10.1016/j.jdermsci.2012.01.001 Hirohata, 2012, Changes in biomarkers focused on differences in disease course or treatment in patients with neuro-Behçet's disease, Intern Med, 51, 3359, 10.2169/internalmedicine.51.8583 Hirohata, 1986, Association of cerebrospinal fluid IgM index with central nervous system involvement in Behcet's disease, Arthritis Rheum, 29, 793, 10.1002/art.1780290614